(c) 2024 PillSync.com

gabapentin 600 mg

1 INDICATIONS AND USAGE GRALISE is indicated for the Management of postherpetic neuralgia. GRALISE is not interchangeable with other gabapentin products because of differing pharmacokinetic profiles that affect the frequency of administration. GRALISE is indicated for the Management of postherpetic neuralgia (PHN). Important Limitation: GRALISE is not interchangeable with other gabapentin products because of differing pharmacokinetic profiles that affect the frequency of administration (See Warnings and Precautions )

Assertio Therapeutics, Inc.

FDA Reported Adverse Reactions
[1] nausea    [2] fatigue    [3] drug ineffective    [4] pain    [5] off label use    [6] headache    [7] diarrhoea    [8] vomiting    [9] dyspnoea    [10] arthralgia   

1 year ago OVAL BROWN SLV 600 gabapentin 600 mg

OVAL BROWN SLV 600

1 year ago OVAL BROWN SLV 600 gabapentin 600 mg

SLV 600 OVAL BROWN

16 HOW SUPPLIED/STORAGE AND HANDLING GRALISE (gabapentin) Tablets are supplied as follows: 300 mg tablets: GRALISE 300 mg tablets are white, oval shaped tablets debossed with "SLV" on one side and "300" on the other side. NDC 13913-004-19 (Bottle of 90) 600 mg tablets: GRALISE 600 mg tablets are beige, oval shaped tablets debossed with "SLV" on one side and "600" on the other side. NDC 13913-005-19 (Bottle of 90) Storage Store at 25°C (77°F); excursions permitted to 15° to 30°C (59° to 86°F) [see USP Controlled Room Temperature]. Keep out of reach of children.


More pills like OVAL SLV 600












DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site